Full Year
-
Financial
Orthofix Reports Third Quarter 2024 Results, Reiterates Full-Year 2024 Financial Guidance, and Introduces New Three-Year Financial Targets
Building on Positive Momentum from Compelling Combination of Profitable, Above-Market Growth with a Stronger Financial Profile LEWISVILLE, Texas, November 7,…
Read More » -
Financial
OrthoPediatrics Corp. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
Record Third Quarter 2024 Revenue Increased 37% Year-over-Year WARSAW, Ind., Nov. 06, 2024 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”)…
Read More » -
Financial
ATEC Reports Third Quarter 2024 Financial Results And Raises Full-Year Guidance
Surgical revenue grew 30%; total revenue grew 27% Full-year revenue and profitability guidance increased Enhanced balance sheet flexibility with $50…
Read More » -
Financial
Orthofix Reports Second Quarter 2024 Results and Raises Full-Year 2024 Financial Guidance
LEWISVILLE, Texas, August 6, 2024–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the second quarter ended June…
Read More » -
Financial
ATEC Reports Second Quarter 2024 Financial Results And Raises Full-Year Guidance
Surgical revenue grew 27% and drove total revenue growth of 25% to $146 million Full-year revenue and profitability guidance increased…
Read More » -
Financial
ATEC Reports First Quarter 2024 Financial Results and Raises Full-Year Guidance
Total revenue grew 27% to $138 million, with 30% growth in surgical revenue Adjusted EBITDA margin expanded 450 basis points…
Read More » -
Financial
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
Establishes Full Year 2024 Revenue Guidance of $112 Million – $116 Million BELGRADE, Mont., April 01, 2024 (GLOBE NEWSWIRE) —…
Read More » -
Financial
Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
Press Release, March 13, 2024 – Kuros Biosciences – Financial highlights Direct MagnetOs sales grew by 163% to CHF 31.7…
Read More » -
Financial
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results
Record full year 2023 revenue of $148.7 million increased 22% compared to prior year WARSAW, Ind., March 06, 2024 (GLOBE…
Read More » -
Financial
Orthofix Reports Fourth Quarter and Full Year 2023 Results
Recent Highlights Fourth quarter 2023 net sales of $200.4 million, an increase of 64% on a reported basis and 7%…
Read More » -
Financial
Vicarious Surgical Reports Fourth Quarter and Full Year 2023 Financial Results
Version 1.0 Surgical System On Track for Cadaveric Testing this SpringAchieves 2023 Cash Burn Objective of $63.4 Million2024 Cash Burn…
Read More » -
Financial
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
— Record revenues of $675 million in 2023 — — Full-year GAAP net income of $42 million and adjusted EBITDA of $214 million — — EXPAREL…
Read More » -
Financial
ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results
FY 2023 Third Party Net Sales from Continuing Operations of $457.2 million FY 2023 Third Party Net Sales from Discontinued…
Read More » -
Financial
ATEC Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Highlights
Full year 2023 total revenue grew 37% to $482 million Full year 2023 adjusted EBITDA margin improved ~890 basis points…
Read More » -
Financial
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance
SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving…
Read More »